News

Glenn J. Jaffe, MD, presents a summary of the results of a confirmatory study on a previous Phase III trial that examined sustained drug delivery for the treatment of uveitis, as well as data on the 36-month results in the second, confirmatory phase 3 study of YUTIQ.

Ted Leng, MD, MS, Byers Eye Institute at Stanford, and medical advisor for Verana Health, talks about data insights for retinal surgeons. Steven D. Schwartz, MD, Stein Eye Institute, UCLA, highlights his AAO presentation, “New Insight into Real-World U.S. Injection Data."

Gene therapy for X-linked retinitis pigmentosa is achieving significant visual gains at 1 year mark.

During Day 1 of AAO 2020, Carl Awh, MD, discusses the Micro-Vacuum Pick, a device for peeling internal limiting membranes that's providing vitreoretinal surgeons an alternative to forceps during surgeries.

At AAO 2020, Fernando Arevalo, MD, PhD, details the use of anti-VEGF therapy for the treatment of retinal arteriolar macroaneurysms that are near the fovea.

Prof. Marie-José Tassignon, past chief and chair, Department of Ophthalmology, Antwerp University and University Hospital Antwerp, Belgium, expands on her AAO presentation by providing an overview of her novel technique in performing a risk-free posterior capsulorhexis.

Chris Brittain, MBBS, BSc, MBA, MRCOphth, vice president and global head of ophthalmology product development for Genentech, provides an overview of the company’s podium presentations from the PDS with ranibizumab to faricimab.

Anne L. Coleman, MD, president of the American Academy of Ophthalmology, offers a preview of its virtual 2020 annual meeting.

The University of California San Francisco brings its vision care and research facilities together at the UCSF Wayne and Gladys Valley Center for Vision.

American Academy of Ophthalmology (AAO) President Anne L. Coleman, MD, PhD, offers a preview of what attendees can look forward to from the academy's 2020 virtual annual meeting — kicking off Nov. 13-15.

Phase 1b data show improved vision and reduced macular edema in patients, with only 3 loading doses and minimal re-treatments.

Results support further research investigating transforming growth factor-β-Induced Gene Human Clone 30 (BIGH3).

Manufacturers are stepping up to design products that will help maximize the safety and efficiency of intravitreal injection.

The benefit is robust across a variety of demographics and baseline disease characteristics, according to data.

Dietary macular pigments, which can now be measured directly and accurately, are hugely important in optimizing visual function, especially as we age.

Silicone rubber balloon scleral buckling is a novel alternative to the current extraocular procedures for treating simple rhegmatogenous retinal detachments. Investigators have found that this surgery may be a novel alternative to the current extraocular procedures for simple RRD.

In one of the first studies of the faceup position, researchers found its use after vitrectomy of rhegmatogenous retinal detachment may be beneficial in some patients.

A team of researchers has found that the diameter of retinal veins may be linked directly to the severity of COVID-19. Assessing the retinal veins may be a part of diagnosing and managing the disease.

Understanding the per-person cost differences with 3 key management strategies for a better-informed treatment selection

How this method of anesthesia may provide benefits to both the patient and physician

High-quality images can be useful for early diagnosis, prognosis, monitoring

Following trends by geographic variation in practice patterns, perceptions toward opioids, and patient population

To maintain treatment quality and patient and staff safety in the SARS-CoV-2 era, it is important to minimize clinic visits and maximize the use of imaging modalities. In addition, extending treatment intervals with longer-acting agents is key to maximizing safety and patients’ vision outcomes.

Euan S. Thomson, PhD, global president of ophthalmic devices at Carl Zeiss Meditec, talks about the “Zeiss Virtual Experience” during the 2020 EURETINA virtual meeting, and how attendees can navigate the booth to find the must-see products Zeiss is highlighting.

Lars Risby, international sales and training manager, Oculus Surgical, discusses how the global pandemic has re-prioritized production lines to enhance sterile product offerings and how the company is working with others in industry to improve overall product lines.

Dr Grazia Pertile, head of the Department of Ophthalmology, Sacrocuore Hospital, Negrar-Verona, Italy, reveals two courses that will be taking place at this year’s EURETINA.

Dr M.M. Alberto Pestano explains how optic neuropathy can present as a masquerade syndrome. He highlighted a case of unilateral infiltrative optic neuropathy that presented as a masquerade syndrome in a man with esophageal adenocarcinoma.

According to Dr Jose Ignacio Fernandez-Vigo, follow-ups can be affected by comorbidities, anxiety about injections, and long waits in the clinic